“Stratifying chronic liver inflammation to predict anti-cancer therapy response”


Event details

Date 17.03.2022 12:1513:30  
Speaker Prof. Dr. Mathias Heikenwälder
Location Online
Category Conferences - Seminars
Event Language English
A Lola and John Grace Distinguished Lecture in Cancer Research

Prof. Dr. Mathias Heikenwälder - Group leader "chronic inflammation and cancer division" at the German Cancer Research Centre in Heidelberg.

Prof. Heikenwälder (*1976) and his group are investigating molecular and cellular mechanisms that cause chronic inflammation, tissue damage, cancer and metastasis. In doing so, he tries to develop new models and therapeutic approaches in close cooperation with clinics. Prof. Heikenwälder studied microbiology and molecular biology in Vienna. After a two-year research period at the Max Delbrück Centre for Medicine in Berlin, he graduated with highest honours in 1999. He then began his doctoral work at the Institute of Neuropathology in Zurich. In 2004, he completed his doctorate at the Institute of Neuropathology (University of Zurich) in the field of prion research. After his habilitation at the Faculty of Medicine at the University Hospital Zurich, he became Max Cloëtta Professor and group leader with the research focus "Inflammation and Cancer" in 2007. In 2010, he became a junior research group leader at the Institute of Virology at Helmholtz Zentrum München and a professor at Technische Universität München. Since mid-2015, Prof. Heikenwälder has been the head of Division F180 "Chronic Inflammation and Cancer" at the German Cancer Research Center in Heidelberg.

Contact for the Zoom access code : Lisa Smith, ISREC Administrative Assistant

There are a limited number of in-person seats in conference room SV 1717, on a first-come, first-served basis - 30 seats maximum.
A QR code or covid vaccination certificate is required for in-person access.

Practical information

  • Informed public
  • Free
  • This event is internal


  • Prof. Freddy Radtke, Director ISREC